FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells. Sperk A, Gabriel A, Koch D, Augsburger A, et al. Leukemia 2024;38:2027-2031.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sperk A, Gabriel A, Koch D, Augsburger A, et al. FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells. Leukemia 2024;38:2027-2031.
PMID: 39014197